How This Tiny Stock (CSE-KBEV) Beat Big Beer To The Green Infused Beverage Bonanza

Koios KBEV

Constellation Brands is a $40 billion behemoth. They’re Corona beer, Modelo, whisky, wine, vodka, you name it.

A few short weeks ago the giant drove global markets a little bit loco by quadrupling its stake in one of Canada’s leading “green” growers. (We can’t say the name of the plant to risk offending sensitive U.S. readers, but you know what it is. It’s big business.)

Suddenly stocks throughout the industry were soaring as investors woke up to what Big Beer + Big Green could do as a team and everyone started making dream matches. These stocks are now the hottest thing in Toronto . . . and with rivals like Molson Coors circling, the heat keeps coming.

But here’s the thing: there’s already a “green” drink on the market, infused with just the same plant Big Beer is spending billions to chase. It comes from a little company called Koios Beverage Corp. (CSE:KBEV). Mostly trades in Canada, but look for KBEVF or SNOVF over the counter in the States.

KBEV is weeks away from getting the first “nootropic” beverages enhanced with CBD cannabidiol molecules. That’s a long way ahead of the giants, which aren’t exactly nimble so you’ve got a big first mover advantage here.

And when those drinks launch in October, they’ll be delivered door to door in the Rocky Mountain High. Check out the eye-catching branding on the van KBEV is going to put on the road:


What’s the goal here that’s got the giants roiled and little guys like KBEV on the move? Only world domination, the kind of ambition that turns a coffeehouse into a Starbucks.

Once upon a time, hard-working people who needed pep were limited to chewing roots and leaves. Coffee hit them like a mind bomb — suddenly the magic brew gave us a hand waking up early and staying focused.

We’re in what they call the “third wave” of coffee now. It started when Starbucks got too big for Seattle and took over the planet. Adjusted for splits, that stock went public back in 1992 at . . . close to $0.20 per share.

Since that “humble start,” coffee has taken shareholders on a 19,480.76% journey that’s literally generated enough wealth to create 70 billionaires, 70,000 millionaires.

KBEV started as a coffee killer. Management was tired of dealing with caffeine and its health profile . . . energy in the morning but also the jitters, the panic attacks, other big side effects.

California is even labelling coffee as a carcinogen. That’s going to scare a few people who currently contribute to what’s now the $225 billion coffee economy. They still need the buzz, but they’ll look for other ways to get it.

That’s a classic competitive opening for ANYBODY who’s not the incumbent to step in. The more people who at least try a coffee detox (223 MILLION hits, by the way, a lot of people are talking about this!), the more might end up trying the KBEV alternative.

One of the biggest “alternatives” is of course the green herbal variety. Huge business, $10 billion in sales already in the states that allow it, $5 billion in Canada now that it’s legal nationwide.

KBEV saw the writing on the wall and got into “cannavated” formulas early.

Unlike wacky drinks, these enhance brain activity. The science is “nootropics,” chemicals formulated to give tired cells a healthy boost. It’s like old-fashioned coffee for a new generation. Testimonials keep coming back to “clarity” and focus.

Add the untapped neurological potential of the new ingredient and the sky’s the limit on how much of the $3 TRILLION beverage market KBEV can capture here.

It’s no coincidence giant beer distributor Constellation invested $4 BILLION to get a toehold in this space. Let them make all the green beer they want. KBEV is aiming at the “smart” energy drink end of the market where Monster and Red Bull play.

And it’s not blue sky either. Even at this stage, the company’s energy drinks in 2,000 stores and has relationships with distributors who can unlock another 80,000 retail outlets.

That’s names like Europa Sports, Muscle Foods USA, KeHE, Wishing-U-Well . . . trend setters in the world of emerging nutrition, enhanced foods, whatever performance-driven people reach for when they need a lift. More are signing up all the time.

And since this is the modern world and not the 15th century origins of coffee, you can bet KBEV sells online. They’re on Amazon like other go-getters and their own store is over here.

Word of mouth moves a lot of units in energy drink land. A casual search for “koios brain” comes up with over 47,000 hits. That’s not huge buzz but it’s a long way from zero. KBEV already has traction, even at this early commercial stage.

This is how cult brands happen and cult brands get a chance to grow into billion-dollar giants. It’s not about past sales. It’s about where KBEV can go from here.

I’m not going to get too deep on the science of how KBEV’s formula stacks up to King Coffee. If you want the names of the chemicals, you’re probably up to date on all the product reviews and all the chatter. (The executive summary is HERE.)

For our purposes, this is the competitive key:

Taking two KOIOS per day will create mental superiority and is less expensive than drinking Starbucks and much healthier than consuming energy drinks and pre-workouts. Koios enhances focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and creates all day mental clarity and energy, without using large amounts of stimulants.

And the science is starting to ramp up fast. Just a few months ago, KBEV started clinical trials in Denver to prove the testimonials right. “Enhances cognition.” Imagine seeing that on a can in the grocery store!

Of course it doesn’t take a lot of first-time customers to move the needle at this stage. From a balance sheet point of view, any growth here will turn heads for awhile, at least until we see where the “base” forms.

Say KBEV is a $7 million company right now. Monster Beverage, the coffee killer of a previous generation, is a $34 billion behemoth, a literal “monster.” It’s carved out a $3.7 billion slice of King Coffee’s giant universe for itself.

If KBEV can grab even 0.18% of that presence . . . which, by the way, is only 1.6% of the overall coffee universe, and only in the USA . . . it’s earned its market cap on a relative basis. Dollar for dollar in sales at that point, KBEV and mighty Monster will be equally valued.

Of course that doesn’t factor in little things like relative growth, which for KBEV will be huge until it finds its natural level. Remember, while sales aren’t zero here, capital has been a constraint. Buzz here has barely started building. We’re not even looking at “cult brand” status . . . yet.

But Monster is “only” growing 10% a year these days so the comparison has got to favor the underdog. And for all we know, mighty Monster has hit a wall that KBEV will either leap or never notice at all!


Once upon a time the tea merchants laughed at this new thing, the “coffee bean.” Now there’s a GREEN alternative.

That’s what it’s all about. Innovation is eternal. We’re a species that craves a bigger and better boost, generation after generation. When the new boost comes along, we grab it. The old beverage champion loses ground.

KBEV has a proprietary blend of the old and the new: unique herbs like “ciwuija,” which is how Tibetans climb mountains. Enzymes and neurotransmitters that make sure all the molecules reach the brain.

It’s already a long way from your dad’s Red Bull. It’s innovation in action. And the Red Bull guys are billionaires. Companies like this are how we build success like that in our lives, as though we were right there with them in the garage, blending up the future.

Imagine how good life would be right now if you’d bought Starbucks back at the equivalent of $0.30 per share. It’s up above $50 last I checked and it’s paid a lot of dividends along the way.

Vision like that takes either brainpower or luck. KBEV products apparently provide plenty of brainpower. Every trader needs to make his own luck . . . you know, “when opportunity knocks?”

After all, Starbucks just sells coffee. Red Bull’s chemicals aren’t “green.” Big Beer is just getting started figuring out its plan here. This could be the craze of all crazes. And KBEV is already here, ready to roll.

Disclaimer :

This is a paid advertisement and all individuals should verify all claims and perform their own due diligence on ​KBEV (and / or any other mentioned companies and / or securities), and read this disclaimer in its entirety.

Capital Equity Review profiles are not a solicitation or recommendation to buy, sell or hold securities. Capital Equity Review is a paid advertiser and is not offering securities for sale. Neither Capital Equity Review nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by Capital Equity Review its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations.

Capital Equity Review does not recommend that the securities profiled should be purchased, sold or held and is not liable for any investment decisions by its readers or subscribers.

Information presented by Capital Equity Review may contain “forward-looking statements ” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance, are not statements of historical fact and may be “forward-looking statements.” Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements may be identified through the use of words such as “expects, ” “will, ” “anticipates,” “estimates,” “believes,” “may,” or by statements indicating that certain actions “may,” “could,” or “might” occur.




By using Capital Equity Review, you agree, without limitation or qualification, to be bound by, and to comply with, these Terms of Use and any other posted guidelines or rules applicable.

The website contains links to other related World Wide Web Internet sites and resources. Capital Equity Review is not responsible for the availability of these outside resources, or their contents, nor does Capital Equity Review endorse nor is Capital Equity Review responsible for any of the contents, advertising, products or other materials on such sites. Under no circumstances shall Capital Equity Review be held responsible or liable, directly or indirectly, for any loss or damages caused or alleged to have been caused by use of or reliance on any content, goods or services available on such sites. Any concerns regarding any external link should be directed to its respective site administrator or webmaster.

You agree to indemnify and hold Capital Equity Review, its officers, directors, owners, agents and employees, harmless from any claim or demand, including reasonable attorneys fees, made by any third party due to or arising out of your use of the website, the violation of these Terms of Use by you, or the infringement by you, or other user of the website using your computer, of any intellectual property or other right of any person or entity. We reserve the right, at our own expense, to assume the exclusive defense and control of any matter otherwise subject to indemnification.

Capital Equity Review is owned and operated by JBN PARTNERS LLC, which is a US based corporation. We are paid advertisers, also known as stock touts or stock promoters, who disseminate favorable information (this “Article”) about publicly traded companies (the “Profiled Issuers”).

​We publish the Information on our website, ​ and in newsletters, text message alerts, audio services, live interviews, featured “research” reports, on message boards and in email communications for specific time periods that are agreed upon between us and the Profiled Issuer and / or third party paying us. Our publication of the Information is known as a “Campaign”. This information may be sent to potential investors at different times that are minutes, hours, days or even weeks apart. Typically, the trading volume and price of a Profiled Issuer’s securities increases after the information is provided to the first group of investors. Therefore, the later an investor receives the Information, the more likely it is that he will suffer trading losses if they purchase the securities of a Profiled Issuer late in a Campaign. We are paid to advertise the Profiled Issuers, ​Koios Beverage Corp. Capital Equity Review has been hired by ​​Koios Beverage Corp.​ for a period beginning on ​May 1, 2018 to publicly disseminate information about (​KBEV) via website and email. We have been compensated $​308,000. We will update any changes to our compensation. We own zero shares of (​KBEV).

Third Parties paying us to market the Profiled Issuer we believe intend to sell their shares they hold while we tell investors to purchase during the Campaign. ​Koios Beverage Corp.. is a penny stock that was illiquid (little to no trading volume) prior to our Campaign, and therefore these securities are subject to wide fluctuations in trading price and volume. During the Campaign the trading volume and price of the securities of each Profile Issuer will likely increase significantly because of the media exposure. When the Campaign ends, the volume and price of the Profiled Issuer will likely decrease dramatically. As a result, investors who purchase during the Campaign and hold shares of the Profiled Issuer when the Campaign ends will probably lose most, if not all, of their investment.

The Information we publish in the Campaign is only a snapshot that provides only positive information about the Profiled Issuers. The Information consists of only positive content. We do not and will not publish any negative information about the Profiled Issuers; accordingly, investors should consider the Information to be one-sided and not balanced, complete, accurate, truthful and / or reliable. We do not verify or confirm any portion of the Information. We do not conduct any due diligence, nor do we research any aspect of the Information including the completeness, accuracy, truthfulness and / or reliability of the Information. We do not review the Profiled Issuers’ financial condition, operations, business model, management or risks involved in the Profiled Issuer’s business or an investment in a Profiled Issuer’s securities.

All information in our Campaign is publicly available information from 3rd party sources and / or the Profiled Issuers and/or the 3rd parties that hire us. We may also obtain the Information from publicly available sources such as the OTC Markets, Google, NASDAQ, NYSE, Yahoo, Bing, the Securities and Exchange Commission’s Edgar database or other available public sources.

We select the stocks we profile and / or pick as we are compensated to advertise them. If an investor relies solely on the Information in making an investment decision it is highly probable that the investor will lose most, if not all, of his or her investment. Investors should not rely on the Information to make an investment decision.

The source of our compensation varies depending upon the particular circumstances of the Campaign. In certain cases, we are compensated by the Profiled Issuers, third party shareholders, and / or other parties related to the Profiled Issuers such as officers and/or directors who will derive a financial or other benefit from an increase in the trading price and/or volume of a Profiled Issuer’s securities.

We make no warranty and / or representation about the Information, including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable and as such, your use of the Information is at your own risk. The Information is provided as is without limitation.

We are not, and do not act in the capacity of any of the following; as such, you should not construe our activities as involving any of the following: an independent adviser or consultant; a fortune teller; an investment adviser or an entity engaging in activities that would be deemed to be providing investment advice that requires registration either at the federal and / or state level; a broker-dealer or an individual acting in the capacity of a registered representative or broker; a stock picker; a securities trading expert; a securities researcher or analyst; a financial planner or one who engages in financial planning; a provider of stock recommendations; a provider of advice about buy, sell or hold recommendations as to specific securities; or an agent offering or securities for sale or soliciting their purchase.

There are numerous risks associated with each Profiled Issuer and investors should undertake a full review of each Profiled Issuer with the assistance of their financial, legal, and tax advisers prior to purchasing the securities of any Profiled Issuer.

We are not objective or independent and have multiple conflicts of interest. The Profiled Issuers and parties hiring us have conflicts of interest. Third parties that have hired us and own shares will sell these shares while we tell investors to purchase, and this selling of the Profiled Issuer’s securities will likely cause investors to suffer losses.

Our publication of the Information involves actual and material conflicts of interest including but not limited to the fact that we receive monetary compensation in exchange for publishing the (favorable) Information about the Profiled Issuers; and we do not publish any negative information, whatsoever, about the Profiled Issuers; in addition to the fact that while we do not own the Profiled Issuer’s securities, the third parties that hired us do, and intend to sell all of these securities during the Campaign while we publish favorable information that instructs investors to purchase, and this selling of the Profiled Issuer’s securities will likely cause investors to suffer losses.

We are not responsible or liable for any person’s use of the Information or any success or failure that is directly or indirectly related to such person’s use of the Information because we have specifically stated that the information is not reliable and should not be relied upon for any purpose. We are not responsible for omissions and / or errors in the Information and we are not responsible for actions taken by any person who relies upon the Information.

We urge Investors to conduct their own in-depth investigation of the Profiled Issuers with the assistance of their legal, tax and / or investment adviser(s). An investor’s review of the Information should include but not be limited to the Profiled Issuer’s financial condition, operations, management, products and / or services, trends in the industry and risks that may be material to the profiled Issuer’s business and other information he and his advisers deem material to an investment decision. An investor’s review should include, but not be limited to a review of available public sources and information received directly from the Profiled Issuers or from websites such as Google, Yahoo, Bing, OTC Markets, NASDAQ, NYSE, or other available public sources.

We are providing you with this disclaimer because we are publishing advertisements about penny stocks. Because we are paid to disseminate the Information to the public about securities, we are required by the securities laws including Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 thereunder, and Section 17(b) of the Securities Act of 1933, as amended (the “Securities Act”), to specifically disclose my compensation as well as other important information, This information includes that we may hold, as well as purchase and sell, the securities of a Profiled Issuer before, during and after we publish favorable Information about the Profiled Issuer. We may urge investors to purchase the securities of a Profiled Issuer while we sell my own shares. The anti-fraud provisions of federal and state securities laws require us to inform you that we may engage in buying and selling of Profiled Issuer’s securities before, during and after the Campaigns.

Any investment in the Profiled Issuers involves a high degree of risk and uncertainty. The securities may be subject to extreme volume and price volatility, especially during the Campaigns. Favorable past performance of a Profiled Issuer does not guarantee future results. If you purchase the securities of the Profiled Issuers, you should be prepared to lose your entire investment. Some of the risks involved in purchasing securities of the Profiled Issuers include, but are not limited to the risks stated below.

We do not endorse, independently verify or assert the truthfulness, completeness, accuracy or reliability of the Information. We conduct no due diligence or investigation whatsoever of the Information or the Profiled Issuers and we do not receive any verification from the Profiled Issuer regarding the Information we disseminate.

If we publish any percentage gain of a Profiled Issuer from the previous day close in the Information, it is not and should not be construed as an indication that the future stock price or future operational results will reflect gains or otherwise prove to be advantageous to your investment.

The Information may contain statements asserting that a Profiled Issuer’s stock price has increased over a certain period of time which may reflect an arbitrary period of time, and is not predictive or of any analytical quality; as such, you should not rely upon the (favorable) Information in your analysis of the present or future potential of a Profiled Issuer or its securities.

The Information should not be interpreted in any way, shape, form or manner whatsoever as an indication of the Profiled Issuer’s future stock price or future financial performance.

You may encounter difficulties determining what, if any, portions of the Information are material or non-material, making it all the more imperative that you conduct your own independent investigation of the Profiled Issuer and its securities with the assistance of your legal, tax and financial advisor.

When 3rd parties that hire us acquire, purchase and / or sell the securities of the Profiled Issuers, it may (a) cause significant volatility in the Profiled Issuer’s securities; (b) cause temporary but unrealistic increases in volume and price of the Profiled Issuer’s securities; (c) if selling, cause the Profiled Issuer’s stock price to decline dramatically; and (d) permit themselves to make substantial profits while investors who purchase during the Campaign experience significant losses.

The securities of the Profiled Issuers are high risk, unstable, unpredictable and illiquid which may make it difficult for investors to sell their securities of the Profiled Issuers.

We may hire third party service providers and stock promoters to electronically disseminate live news regarding the Profiled Issuers, yet we have no control over the content of and do not verify the information that the Profiled Issuers and/or third party service providers publish. These third party service providers are likely compensated for providing positive information about the Issuer and may fail to disclose their compensation to you.

If a Profiled Issuer is a SEC reporting company, it could be delinquent (not current) in its periodic reporting obligations (i.e., in its quarterly and annual reports), or if it is an OTC Markets Pink Sheet quoted company, it may be delinquent in its Pink Sheet reporting obligations, which may result in OTC Markets posting a negative legend pertaining to the Profiled Issuer at, as follows: (i) “Limited Information” for companies with financial reporting problems, economic distress, or that are unwilling to file required reports with the Pink Sheets; (ii) “No Information,” which characterizes companies that are unable or unwilling to provide any disclosure to the public markets, to the SEC or the Pink Sheets; and (iii) “Caveat Emptor,” signifying buyers should be aware that there is a public interest concern associated with a company’s illegal spam campaign, questionable stock promotion, known investigation of a company’s fraudulent activity or its insiders, regulatory suspensions or disruptive corporate actions.

If the Information states that a Profiled Issuer’s securities are consistent with the future economic trends or even if your independent research indicates that, you should be aware that economic trends have their own limitations, including: (a) that economic trends or predictions may be speculative; (b) consumers, producers, investors, borrowers, lenders and/or government may react in unforeseen ways and be affected by behavioral biases that we are unable to predict; (c) human and social factors may outweigh future economic trends that we state may or will occur; (d) clear cut economic predictions have their limitations in that they do not account for the fundamental uncertainty in economic life, as well as ordinary life; (e) economic trends may be disrupted by sudden jumps, disruptions or other factors that are not accounted for in economic trends analysis; in other words, past or present data predicting future economic trends may become irrelevant in light of new circumstances and situations in which uncertainty becomes reality rather than predicted economic outcome; or (f) if the trend predicted involves a single result, it ignores other scenarios that may be crucial to make a decision in the event of unknown contingencies.

The Information is presented only as a brief snapshot of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities. You should consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at, or other electronic media, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the; (c) obtaining and reviewing publicly available information contained in commonly known search engines such as Google; and (d) consulting investment guides at and You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and the OTC Markets and/or have negative legends and designations at

No securities commission or other regulatory authority in Canada or any other country or jurisdiction has in any way passed upon this information and no representation or warranty is made by to that effect. The information is not a substitute for independent professional advice before making any investment decisions. The CSE (Canadian Securities Exchange) has not reviewed the information in this Article and does not accept responsibility for the adequacy or accuracy of it.

Capital Equity Review , reserves the right, at its sole discretion, to change, modify, add and/ or remove all or part of this Disclaimer and / or Terms of Use at any time.